Role of Systemic Therapy for Advanced/Metastatic Gastric Carcinoma in First Line Treatment: A Systematic Review and Network Meta-Analysis (PODIUM PRESENTATION)
Mohsen Yaghoubi |Associate Principal Scientist, Certara
Immunotherapies and/or targeted agents in advanced/metastatic gastric cancer (A/MGC) offer more treatment combinations than standard systemic chemotherapies. A systematic literature review (SLR) and network meta-analysis (NMA) was conducted to evaluate the relative efficacy and safety of first-line systemic therapies in A/MGC.
Review of Health Technology Assessment (HTA) and recommendations for the introduction of higher-valency Pneumococcal Conjugated Vaccine (PCV) in 4 European countries, the United Kingdom (UK), and the United States (US).
Roxane Noharet-Koenig, Katarzyna Lasota, Pascaline Faivre, Edith Langevin |